Iradimed Corporation (NASDAQ:IRMD) Files An 8-K Results of Operations and Financial Condition
Item 2.02
On February 6, 2020, iRadimed Corporation (the “Company”) issued a press release (the “Press Release”) announcing its financial results for the fourth quarter ended December 31, 2019. A copy of the Press Release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information in this Item 2.02, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that Section. Furthermore, such information, including Exhibit 99.1, shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
(d) Exhibits
| 99.1 | Press release dated February 6, 2020. |
IRADIMED CORP Exhibit
EX-99.1 2 tm206851d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 IRADIMED CORPORATION Announces Fourth Quarter 2019 Financial Results ·Reports fourth quarter 2019 revenue of $10.9 million,…
To view the full exhibit click here
About Iradimed Corporation (NASDAQ:IRMD)
IRADIMED CORPORATION (IRADIMED) develops, manufactures, markets and distributes Magnetic Resonance Imaging (MRI) compatible products, and provides non-magnetic intravenous (IV) infusion pump systems. The Company operates through development, manufacture and sale of MRI compatible products and IV infusion pump systems for use by hospitals and acute care facilities during MRI procedures segment. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor, non-ferrous part and other features in order to deliver anesthesia and other IV fluids during various MRI procedures. MRI compatible IV infusion pump system includes the 3860+ MRI compatible IV infusion pump, single-use IV tubing sets, a non-magnetic pole and a lithium battery. In addition, it offers optional upgrade systems, including the 3865 Remote Display/Control, 3861 Side Car, Dose Error Reduction System (DERS) and SpO2 monitor.
